Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Burapitant in Women With Overactive Bladder
NCT00564226Phase 2Completed
- Sponsor
- Sanofi
- Start
- Nov 2007
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of burapitant in overactive bladder (OAB), sponsored by Sanofi. Started Nov 2007; status: completed.
02
Drugs
burapitant
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00564226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00564226.